Company / FCF Margin
Vertex Pharmaceuticals FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
26.6%
FY2025
5-year range
-7.2% / 44.0%
FY2021-FY2025
Trend
+471.1%
vs FY2024
Sector context
#19 of 134
Health Care
What the data says
FCF Margin changed +471% YoY in FY2025, a notable deviation from the 9-year average annual change of +132%.
Based on SEC 10-K filings.
26.6% in FY2025 with a 5-year CAGR of -21.6%. Top quartile in the Health Care sector.
Declined from 33.8% to 26.6% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -17.3pp
- 5-Year Change
- -21.6pp
- 10-Year Change
- -
Sector benchmark
Top 14% in Health CareTop 14% of 134This company 26.6% Sector average -637.8%
▼
+104.2% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 471.1% year-over-year.
- Currently 664.4pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 26.6% | +471.1% |
| FY2024 | -7.2% | -121.2% |
| FY2023 | 33.8% | -23.1% |
| FY2022 | 44.0% | +38.2% |
| FY2021 | 31.8% | -34.1% |
| FY2020 | 48.2% | +34.4% |
| FY2019 | 35.9% | -6.9% |
| FY2018 | 38.6% | -63.0% |
| FY2017 | 104.3% | +888.7% |
| FY2016 | 10.5% | +126.5% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026